TherapeuticsMD reported $-11.99M in Cost of Sales for its fiscal quarter ending in December of 2022.





Cost Of Sales Change Date
AbbVie USD 4.22B 329M Mar/2026
Cipla INR 26.32B 2.79B Mar/2026
Clal Biotechnology ILS 16.49M 2.64M Jun/2022
Compugen USD 3.54M 1.89M Dec/2025
CSL USD 3.87B 2.08B Dec/2025
Grifols EUR 1.51B 184.45M Dec/2025
Novo Nordisk DKK 1.95B 10.94B Jun/2025
Pfizer USD 4.59B 1.7B Mar/2026
TherapeuticsMD USD -11.99M 12.34M Dec/2022